Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay-Reference-Cited by-同舟云学术

Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay

Published:2019-10-25 Issue:2 Volume:27 Page:266-276
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Christensen Troels Dreier^ORCID,Buhl Anna Sofie Kappel,Christensen Ib Jarle,Buhl Ida Kappel,Balslev Eva,Knoop Ann S.,Danø Hella,Glavicic Vesna,Luczak Adam,Langkjer Sven Tyge,Linnet Søren,Jakobsen Erik Hugger,Bogovic Jurij,Ejlertsen Bent,Rasmussen Annie,Hansen Anker,Knudsen Steen,Jensen Peter Buhl,Nielsen Dorte

Funder

Kræftens Bekæmpelse

Innovationsfonden

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-019-01017-7.pdf

Reference33 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 .

2. Van Poznak C, Harris LN, Somerfield MR. Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: american society of clinical oncology clinical practice guideline. J Oncol Pract Am Soc Clin Oncol. 2015;11(6):514–6. https://doi.org/10.1200/jop.2015.005215 .

3. Cardoso F, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Diéras V, El Saghir NS, Eniu A, Senkus E, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen BV, Costa A, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Papadopoulos E, Xu B, Norton L, Winer EP, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†. Ann Oncol. 2018;29(8):1634–57. https://doi.org/10.1093/annonc/mdy192 .

4. Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L (2015) Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107(6):djv048. https://doi.org/10.1093/jnci/djv048

5. Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Pernault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E. 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). Breast (Edinburgh, Scotland). 2017;31:244–59. https://doi.org/10.1016/j.breast.2016.10.001 .

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid deep model for predicting anti-cancer drug efficacy in colorectal cancer patients;Web Intelligence;2023-12-08

2. Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer;Scientific Reports;2022-07-27